G Medical Innovations Revenue and Competitors

Israel ,

Location

$30.8M

Total Funding

Estimated Revenue & Valuation

  • G Medical Innovations's estimated annual revenue is currently $9.8M per year.(i)
  • G Medical Innovations's estimated revenue per employee is $203,938
  • G Medical Innovations's total funding is $30.8M.

Employee Data

  • G Medical Innovations has 48 Employees.(i)
  • G Medical Innovations grew their employee count by 26% last year.

G Medical Innovations's People

NameTitleEmail/Phone
1
CTO & Business DevelopmentReveal Email/Phone
2
SVP Sales, North AmericaReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
Director Logistics and Business Development ManagerReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Clinical DirectorReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Director Product Technology and Product SupportReveal Email/Phone
9
Clinical ManagerReveal Email/Phone
10
Purchasing Manager and Eng.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is G Medical Innovations?

G Medical Innovations (ASX: GMV) is a next-generation mobile health company. We believe in transforming personal healthcare by developing innovative mobile-health solutions that provide comprehensive, medical-grade diagnostics using remote and personalized platforms. Founded in 2014, we strive to increase healthcare efficiency, empower physicians, caregivers and consumers, and improve personal quality of life by providing a higher level of healthcare that is accessible to more people worldwide. G Medical Innovations operates in the USA, Europe, China, the Middle East and Australia. The Company has established a new and advanced manufacturing site in China, Guangdong, and operates a wholly owned subsidiary, G Medical Diagnostic Services, Inc. that provides arrhythmia monitoring and diagnostics in the USA. The G Medical PRIZMA offering is an innovative FDA cleared/CE approved medical smartphone case that transforms any smartphone into a medical monitoring and diagnostic device. With PRIZMA, users can independently manage their health by continuously measuring, monitoring and sharing vital signs with caregivers and loved ones. A further offering in development, the Vital Monitoring System (VSMS) with G Medical Patch (GMP) is a health monitoring solution that provides accurate diagnostics in real-time and offers a heightened level of care for patient monitoring in all healthcare settings. This modular, easy-to-use, clinical grade solution utilizes patented wireless technologies, proprietary information technology and service platforms. The solutions can enhance patient care and help healthcare providers increase efficiency, decrease liability and reduce the number of readmissions. (Note: The GMP/VSMS device is currently under CE and FDA evaluation and it is not for sale in the US)

keywords:N/A

$30.8M

Total Funding

48

Number of Employees

$9.8M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

G Medical Innovations News

2022-04-17 - Yacov Geva. President and CEO, G Medical Innovations and ...

Yacov Geva. President and CEO, G Medical Innovations and Rosen Plevneliev former President of Bulgaria (PRNewsfoto/IMPROVATE). By IMPROVATE...

2022-04-13 - (Correction) G Medical Innovations Holdings Ltd Announces $7.5 Million Private Placement

TEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth,...

2022-04-06 - G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Sees ...

G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Sees Large Decline in Short Interest. Posted by admin on Apr 16th, 2022.

2021-09-15 - G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%

Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021 Accelerating growth strategy with expansion of Prizma and Cardiac sales team UnityPoint Prizma vital signs pilot study to start end of September; new cardiac services program underway Continued ...

2021-06-29 - G Medical Innovations Holdings Ltd. Announces Closing of $15.0 Million Initial Public Offering

TEL AVIV and NEW YORK , June 29, 2021 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, t ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.7M8911%N/A
#2
N/A1069%N/A
#3
N/A1069%N/A
#4
$19.2M12033%N/A